Effects of Dexmedetomidine Preconditioning on Hepatic Ischemia-Reperfusion Injury in Rats
Transplantation Proceedings · 2026
DOI: 10.1016/j.transproceed.2026.08.001 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transplantation Proceedings, 2026. Verfasst von Jeong Eun Lee und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology and Pain Medicine, School of Medicine, Kyungpook National University, Kyungpook National University Chilgok Hospital, Da…. Hauptthemen laut MEDLINE: Dexmedetomidine, Reperfusion Injury, Liver, Adrenergic alpha-2 Receptor Agonists. Die Arbeit nennt 29 Literaturangaben.
Abstract (Originalsprache)
OBJECTIVES: Dexmedetomidine (Dex), an α2 adrenoceptor selective agonist, has analgesic and sedative effects. Dex preconditioning also can reduce organ damage against ischemia-reperfusion (IR) injury in rat models. We divided the study into two experiments to investigate the protective effects of Dex on hepatic IR injury (IRI) according to dose and the involvement of nitric oxide (NO) in Dex preconditioning, using the NO synthase inhibitor N-nitro-l-arginine methyl ester (L-NAME) and the α2 adrenoceptor blocker atipamezole. MATERIALS AND METHODS: A total of 36 rats were assigned 4 to each group. In the first experiment, the degree of hepatic IR damage was compared at Dex 30, 50, and 70 μg/kg in a hepatic IRI model. In the second experiment, using Dex 50, which showed the most protective effect in the first experiment, serum transaminase, hepatic tissue malondialdehyde levels, hepatic tissue superoxide dismutase activity, and the degree of histopathological assessment were observed in each group using L-NAME and atipamezole, respectively. RESULTS: Dex preconditioning attenuated hepatic IRI, and the degree of histopathological damage decreased in proportion to the increase in the concentration of Dex. When NO production was inhibited using L-NAME, the histoprotective effect of Dex was reversed; although histopathological hepatic damage increased, biochemical analysis showed that the protective effect of Dex was still remained compared to atipamezol. CONCLUSIONS: Dex preconditioning increased tissue-protective effects against IRI in proportion to the concentration of Dex. Additionally, it is observed that NO plays a partial role in the hepatoprotective effects of Dex compared to α2 adrenoceptor effect.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology and Pain Medicine, School of Medicine, Kyungpook National University, Kyungpook National University Chilgok Hospital, Daegu, Republic of Korea. Electronic address: aneslee@knu.ac.kr.
- Department of Anesthesiology and Pain Medicine, School of Medicine, Kyungpook National University, Kyungpook National University Chilgok Hospital, Daegu, Republic of Korea.
- Department of Anesthesiology and Pain Medicine, School of Medicine, Kyungpook National University, Kyungpook National University Hospital, Daegu, Republic of Korea.
Zitieren
APA
Lee, J. E., Hwang, Y. J., Jung, H., Lim, D. G., & Kwak, K. H. (2026). Effects of Dexmedetomidine Preconditioning on Hepatic Ischemia-Reperfusion Injury in Rats. Transplantation Proceedings. https://doi.org/10.1016/j.transproceed.2026.08.001
Vancouver
Lee JE, Hwang YJ, Jung H, Lim DG, Kwak KH. Effects of Dexmedetomidine Preconditioning on Hepatic Ischemia-Reperfusion Injury in Rats. Transplantation Proceedings. 2026. doi:10.1016/j.transproceed.2026.08.001
BibTeX
@article{Lee2026,
author = {Lee, Jeong Eun and Hwang, Ye Ji and Jung, Hoon and Lim, Dong Gun and Kwak, Kyung Hwa},
title = {Effects of Dexmedetomidine Preconditioning on Hepatic Ischemia-Reperfusion Injury in Rats},
journal = {Transplantation Proceedings},
year = {2026},
doi = {10.1016/j.transproceed.2026.08.001}
}
EUVIMED